Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00194220 · ClinicalTrials.gov registry record

Infertility Markers in Serum, Urine, and Follicular Fluid

A clinical trial of Infertility, sponsored by University of Pennsylvania.

Completed
Registry status
1,235
Enrollment target
1
Study location

NCT00194220 is a study of Infertility that has completed, run by University of Pennsylvania. The registered enrollment target is 1,235 participants, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00194220, a study of Infertility, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
1,235 participants
Enrollment target
1
Study location

Study Summary

This study is only collecting specimens from current patients of PENN Fertility Care. The purpose of this investigation is to assess if markers of oxidative stress that are known to be associated with other medical conditions can be detected in women undergoing infertility treatment and normal women of similar age. Oxidative stress may affect a woman's eggs or the follicular cells that surround and nurture them. Other markers of to be investigated include markers of cellular aging and DNA structural changes. Presence of these markers will be compared in blood and urine samples taken during infertility treatment, and follicular fluid at the time of IVF (if applicable).

Conditions Studied

Study Locations (1)

Pennsylvania

  • University of Pennsylvania Reproductive Research Unit - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,235 participants
Start Date 2002-09
Est. Completion 2013-02

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00194220

The ClinicalTrials.gov registry entry for NCT00194220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,235 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT00194220 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00194220 about?

NCT00194220 is a clinical study titled "Infertility Markers in Serum, Urine, and Follicular Fluid". This study is only collecting specimens from current patients of PENN Fertility Care. The purpose of this investigation is to assess if markers of oxidative stress that are known to be associated with other medical conditions can be detected in women undergoing infertility treatment and normal wome...

What is the current status of trial NCT00194220?

This trial is currently completed. The enrollment target is 1,235 participants. The study started on 2002-09. Estimated completion is 2013-02.

What conditions does trial NCT00194220 study?

This clinical trial studies the following conditions: Infertility.

Who is sponsoring clinical trial NCT00194220?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00194220 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.